Effects of food restriction on the hypothalamic prepro-orexin gene expression in genetically obese mice

Brain Research Bulletin

Volumn 51, Issue 6, 2000, Pages 515-521

  Yamamoto, Yukiyo ^a   Ueta, Yoichi ^a   Serino, Ryota ^a   Nomura, Masayoshi ^a   Shibuya, Izumi ^a   Yamashita, Hiroshi ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Food restriction; Hypocretin; In situ hybridization histochemistry; Neuropeptide Y; Obese; Orexin

Indexed keywords

LEPTIN; NEUROPEPTIDE Y; OREXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEEDING; FOOD INTAKE; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; HISTOCHEMISTRY; HYPOTHALAMUS; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL;

ANIMALS; ARCUATE NUCLEUS; BLOOD GLUCOSE; BODY WEIGHT; FOOD DEPRIVATION; GENE EXPRESSION REGULATION; HYPOTHALAMIC AREA, LATERAL; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; NEUROPEPTIDE Y; NEUROPEPTIDES; PROTEIN PRECURSORS; RNA, MESSENGER; TIME FACTORS;

EID: 0034065518     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(99)00271-3     Document Type: Article

References (42)

1. Ahima R.S., Prabakaran D., Mantzoros C., Qu D., Lowell B., Maratos-Flier E., Flier J.S. Role of leptin in the neuroendocrine response to fasting. Nature. 382:1996;250-252.
2. Ahima R.S., Prabakaran D., Flier J.S. Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding, implications for energy homeostasis and neuroendocrine function. J. Clin. Invest. 101:1998;1020-1027.
3. Beck B., Ricky S. Hypothalamic hypocretin/orexin and neuropeptide Y Divergent interaction with energy depletion and leptin . Biochem. Biophys. Res. Commun. 258:1999;119-122.
4. Bernardis L.L., Bellinger L.L. The lateral hypothalamic area revisited Neuroanatomy, body weight regulation, neuroendocrinology and metabolism . Neurosci. Biobehav. Rev. 17:1993;141-193.
5. Bernardis L.L., Bellinger L.L. The lateral hypothalamic area revisited Ingestive behavior . Neurosci. Biobehav. Rev. 20:1996;189-287.
6. Billington C.J., Briggs J.E., Grace M., Levine A.S. Effects of intracerebroventricular injection of neuropepride Y on energy metabolism. Am. J. Physiol. 260:1991;R321-R327.
7. Brady L.S., Smith M.A., Gold P.W., Herkenhan M. Altered expression of hypothalamic neuropeptide mRNA in food-restricted and food-derived rats. Neuroendocrinology. 52:1990;441-447.
8. Chen H., Charlat O., Tartaglia L.A., Woolf E.A., Weng X., Ellis S.J., Lakey N.D., Culpepper J., Moore K.J., Breibart R.E., Duyk G.M., Tepper R.I., Morgenstern J.P. Evidence that the diabetes gene encodes the leptin receptor Identification of a mutation in the leptin receptor gene in db/db mice . Cell. 84:1996;491-495.
9. Churai S.C. Jr, Brown A.W., Kim J., Hennessey K.L., Leibel R.L., Hirsch J. Food deprivation and hypothalamic neuropeptide gene expression. Effects of strain background and the diabetes mutation. Mol. Brain Res. 11:1991;291-299.
10. Chua S.C. Jr, Chung W.K., Wu-Peng X.S., Zhang Y., Liu S.-M., Tartaglia L., Leibel R.L. Phenotypes of mouse diabetes and rat fatty due to mutations in the ob (leptin) receptor. Science. 271:1996;994-996.
11. Chua S.C. Jr, White D.W., Wu-Peng X.S., Liu S.-M., Okada N., Kershaw E.E., Chung W.K., Power-Kehoe L., Chua M., Tartaglia L.A., Leibel R.L. Phenotype of fatty due to gln269pro mutation in the leptin receptor(lepr). Diabetes. 45:1996;1141-1143.
12. Clark J.T., Kalra P.S., Crowley W.R., Kalra S.R. Neoropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology. 115:1984;427-429.
13. Da Silvia B.A., Bjørbæk C., Uotani S., Flier J.S. Functional properties of leptin receptor isoforms containing the gln → pro extracellular domain mutation of the fatty rat. Endocrinology. 139:1998;3681-3690.
14. De Lecea L., Kilduff T.S., Peyron C., Gao X.-B., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L.F., Gautvik V.T., Bartlett F.S. II; Frankel, W. N.; Van den Pol A. N.; Bloom, F. E.; Gautvik K.M., Sutcliffe J.G. The hypocretins Hypothalamus-specific peptides with neuroexcitatory activity . Proc. Natl. Acad. Sci. USA. 95:1998;322-327.
15. Dryden S., Frankish H.M., Wang Q., Pickavance L., Williams G. The serotonergic agent fluoxetine reduces neuropeptide Y levels and neuropeptide Y secretion in the hypothalamus of lean and obese rats. Neuroscience. 72:1996;557-566.
16. Erickson J.C., Hollopeter G., Palmiter R.D. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science. 274:1996;1704-1707.
17. Franklin K.B.J., Paxinos G. The mouse brain in stereotaxic coordinates. 1997;Academic Press, Sydney.
18. Gautvik K.M., De Lecea L., Gautvik V.T., Danielson P.E., Tranque P., Dopazo A., Bloom F.E., Sutcliffe J.G. Overview of the most prevalent hypothalamus-specific mRNAs, as identified by directional tag PCR subtraction. Proc. Natl. Acad. Sci. USA. 93:1996;8733-8738.
19. Hakansson M.L., De Lecea L., Sutcliffe J.G., Yanagisawa M., Meister B. Leptin receptor- and STAT3-immunoreactivities in hypocretin/orexin neurones of the lateral hypothalamus. J. Neuroendocrinol. 11:1999;653-663.
20. Lee G.-H., Proenca R., Montez J.M., Carroll K.M., Darvishzadeh J.G., Lee J.I., Freidman J.M. Abnormal splicing of the leptin receptor in diabetic mice. Nature. 379:1996;632-635.
21. Lubkin, M.; Stricker-Krongrad, A. Independent feeding and metabolic actions of orexin in mice. Biochm. Biophys. Res. Commun. 253:241-245; 1998.
22. Maffe M., Hallas J., Ravussin E., Pratley R.E., Lee G.H., Zhang Y., Fei H., Kim S., Lallone R., Ranganathan S., Kern P.A., Friedman J.M. Leptin levels in human and rodent Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects . Nat. Med. 11:1995;1155-1161.
23. Marks J.L., Porte D. Jr, Stahl W., Baskin D.G. Localization of insulin receptor mRNA in rat brain by in situ hybridization. Endocrinology. 127:1990;3234-3236.
24. Morley J.E., Levine A.S., Gosnell B.A., Kneip J., Grace M. Effect of neuropeptide Y on ingestive behaviors in the rat. Am. J. Physiol. 252:1987;R599-R609.
25. Morley J.E., Hernandez E.N., Food J.F. Neuropeptide Y increases food intake in mice. Am. J. Physiol. 253:1987;R516-R522.
26. Oomura, Y. Input-output organization in the hypothalamus relating to food intake behavior. Handbook of the hypothalamus (Vol. 2). New York: Marcel Dekker; 1980:557-620.
27. Oomura Y., Kita H. Insulin acting as a modulator of feeding through the hypothalamus. Diabetologia. 20:1981;290-298.
28. Oomura Y., Ooyama H., Sugimori M., Nakamura T., Yamada Y. Glucose inhibition of the glucose-sensitive neuron in the rat lateral hypothalamus. Nature. 247:1974;284-286.
29. Pesonen U., Huupponen R., Rouru J., Koulu M. Hypothalamic neuropeptide expression after food restriction in Zucker rats Evidence of persistent neuropeptide Y gene activation . Mol. Brain Res. 16:1992;255-260.
30. Saad M.J.A., Araki E., Mirapleix M., Rothenberg P.L., White M.F., Kahn C.R. Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance. J. Clin. Invest. 90:1992;1839-1949.
31. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R.S., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.-S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior . Cell. 92:1998;573-585.
32. Sanacorca G., Kershaw M., Finkelstein J.A., White J.D. Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation. Endocrinology. 127:1991;730-737.
33. Schwartz, M. W.; Sipols, A. J.; Marks, J. L.; Sanacora, G.; White, J. D.; Scheurink, A.; Kahn, S. E.; Baskin, D. G.; Woods, S. C.; Figlewicz, D. P.; Porte, D., Jr. Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology 130:3608-3616; 1992.
34. Schwarts M.W., Baskin D.G., Bukowski T.R., Kuijper J.L., Foster D., Lasser G., Prunkard D.E., Porte D. Jr, Woods S.C., Seeley R.J., Weigle D.S. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes. 45:1996;531-535.
35. Shian L.R., Lin M.T. Insulin acts on hypothalamic glucose-facilitated neurons to induce hyperglycemia and hyperinsulinemia in the rat. Experienta. 47:1991;942-944.
36. Sredy J., Sawicki D.R., Flam B.R., Sullivan D. Insulin resistance is associated with abnormal dephosphorylation of a synthetic phosphopeptide corresponding to the major autophosphorylation sites of the insulin receptor. Metabolism. 44:1995;1074-1081.
37. Stephens T.W., Basinski M., Bristow P.K., Bue-Vallesky J.M., Burgett S.G., Craft L., Hale J., Hoffmann J., Hsiung H.M., Kriauciunas A., MacKellar W., Rosteck P.R. Jr, Schoner B., Smith D., Tinsley F.C., Zhang X.-Y., Heiman M. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 377:1995;530-532.
38. Wilding J.P.H., Ajala M.O., Lambert P.D., Bloom S.R. Additive effects of lactation and food restriction to increase hypothalamic neuropeptide Y mRNA in rats. J. Endocrinol. 152:1997;365-369.
39. Wilding J.P.H., Gilbey S.G., Bailey C.J., Batt R.A.L., Willians G., Ghatei M.A., Bloom S.R. Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. Endocrinology. 132:1993;1939-1944.
40. Yamamoto Y., Ueta Y., Date Y., Nakazato M., Hara Y., Serino R., Nomura M., Shibuya I., Matukura S., Yamashita H. Down regulation of the prepro-orexin gene expression in genetically obese mice. Mol. Brain Res. 65:1998;14-22.
41. Zang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature. 372:1994;425-432.
42. Zarjevski N., Cusin I., Vettor R., Rohner-Jeanrenaud F., Jeanrenaud B. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology. 133:1993;1753-1758.